Amarenco, P., Goldstein, L. B., Sillesen, H., Benavente, O., Zweifler, R. M., Callahan, A., . . . Welch, K. M. A. (2010). Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: Findings from the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke, 41(3), . https://doi.org/10.1161/STROKEAHA.109.564781
Chicago-Zitierstil (17. Ausg.)Amarenco, Pierre, Larry B. Goldstein, Henrik Sillesen, Oscar Benavente, Richard M. Zweifler, Alfred Callahan, Michael G. Hennerici, Justin A. Zivin, und K. Michael A. Welch. "Coronary Heart Disease Risk in Patients with Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial." Stroke 41, no. 3 (2010). https://doi.org/10.1161/STROKEAHA.109.564781.
MLA-Zitierstil (9. Ausg.)Amarenco, Pierre, et al. "Coronary Heart Disease Risk in Patients with Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial." Stroke, vol. 41, no. 3, 2010, https://doi.org/10.1161/STROKEAHA.109.564781.